TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • September 21st, 2009 • Maxygen Inc • Services-commercial physical & biological research • New York
Contract Type FiledSeptember 21st, 2009 Company Industry JurisdictionThis Technology License Agreement (this “Agreement”) is entered into as of the 18th day of September, 2009 (“Effective Date”) by and between Maxygen, Inc., a Delaware corporation with its principal place of business at 515 Galveston Drive, Redwood City, California 94063 (“Maxygen”), and Perseid Therapeutics LLC, a Delaware limited liability company with its principal place of business at 515 Galveston Drive, Redwood City, California 94063 (“CPC”). Maxygen and CPC are each referred to herein by name or, individually, as a “Party” or, collectively, as the “Parties.”
TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • July 1st, 2009 • Maxygen Inc • Services-commercial physical & biological research • New York
Contract Type FiledJuly 1st, 2009 Company Industry JurisdictionThis Technology License Agreement (this “Agreement”) is entered into as of the th day of , 2009 (“Effective Date”) by and between Maxygen, Inc., a Delaware corporation with its principal place of business at 515 Galveston Drive, Redwood City, California 94063 (“Maxygen”), and CPC, a Delaware limited liability company with its principal place of business at 515 Galveston Drive, Redwood City, California 94063 (“CPC”). Maxygen and CPC are each referred to herein by name or, individually, as a “Party” or, collectively, as the “Parties.”